Breakoutwatch Weekly Summary 09/29/2023

You are receiving this email because you are or were a BreakoutWatch.com subscriber, or have subscribed to our weekly newsletter.
To read this newsletter on the site, click here: Newsletter .

Contents

The newsletter has been absent for a few weeks as I have concentrated on correcting some data problems introduced by a hack of the database. I believe all stock data is now correct and watchlist filters are working again. Next week I depart for 4 weeks on a European vacation but will try to produce this newsletter remotely.

Market Summary

Fed surprises with higher-for-longer forecast

The major U.S. equity benchmarks declined for the week as investors reacted to hawkish forecasts from the Federal Reserve’s latest meeting and rising U.S. Treasury yields. The S&P 500 Index recorded its largest one-day loss in six months on Thursday on its way to a third-straight losing week. [more...]

Major Index Performance

Dow Jones
Last Close 33666.3
Wk. Gain -0.71 %
Yr. Gain -2.73 %
Trend Down
Dow Jones
S&P 500
Last Close 4299.7
Wk. Gain -0.25 %
Yr. Gain -3.27 %
Trend Down
S&P 500
NASDAQ Comp.
Last Close 13201.3
Wk. Gain 0.22 %
Yr. Gain -3.43 %
Trend Down
NASDAQ Comp.
Russell 2000
Last Close 13201.3
Wk. Gain 646.4 %
Yr. Gain 614.47 %
Trend Down
Russell 2000

Performance by Sector

Sector Wk. Change % Yr. Change % Trend
Consumer Discretionary -0.35 23.23 Down
Consumer Staples -2 -4.73 Down
Energy 2.84 7.96 Up
Finance -0.91 -1.87 Down
Health Care -0.5 -4.41 Down
Industrials 0.64 7.63 Down
Technology -0.18 30.68 Down
Materials 0.51 1.49 Down
REIT -2.19 -8.54 Down
Telecom 0.55 29.88 Down
Utilities -7.19 -17.87 Down

Breakouts This Week Still Within 5% of Breakout Price (Limit 20 top C Score)

Watchlist Symbol Company Industry C Score* % Gain
*C score is our assessment of a Stock's correlation to CAN SLIM principles. It combines a stock's Technical and Fundamental merits and is expressed as a percentage.

Breakdowns within 5% of Breakdown Price

Watchlist Symbol Company Industry C Score* % Loss
There were no Breakdowns still within 5% of breakdown price this week
*C score is our assessment of a Stock's correlation to CAN SLIM principles. It combines a stock's Technical and Fundamental merits and is expressed as a percentage.

Cup and Handle Chart of the Week

Aug. 16, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the achievement of First-Patient-In for the company-sponsored Phase 2 clinical trial evaluating darovasertib as neoadjuvant and adjuvant therapy in primary uveal melanoma (UM) patients.